List of works - Rony Dahan

A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance

scientific article published on 29 September 2012

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

scientific article published on 24 November 2021

Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope

scientific article published on 3 October 2013

BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patches

scientific article published on 04 March 2019

Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement

scientific article published in September 2016

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

scientific article

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

scientific article published on 12 October 2015

HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes

scientific article published on October 2004

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis

scientific article

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

scientific article published on 19 May 2016

Signaling by Antibodies: Recent Progress

scientific article

Single-cell genomic approaches for developing the next generation of immunotherapies

scientific article published on 03 February 2020

T-cell-receptor-like antibodies - generation, function and applications

scientific article published on 24 February 2012

TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes

scientific article published on 12 April 2011

Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement

scientific article published on 25 May 2016

Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity

article published in the Proceedings of the National Academy of Sciences of the United States of America

Type I and type II Fc receptors regulate innate and adaptive immunity

scientific article

List of works by Rony Dahan

A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope

BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patches

Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

Signaling by Antibodies: Recent Progress

Single-cell genomic approaches for developing the next generation of immunotherapies

T-cell-receptor-like antibodies - generation, function and applications

TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes

Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement

Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity

Type I and type II Fc receptors regulate innate and adaptive immunity